Enanta Pharmaceuticals (ENTA) Amortizatization of Intangibles (2012 - 2026)
Enanta Pharmaceuticals posted quarterly Amortizatization of Intangibles of -$302000.0 for Q1 2026, up 62.99% year-on-year from -$185287.2 in Q1 2025, and down 1410.0% on a QoQ basis from -$20000.0 in Q4 2025.
Enanta Pharmaceuticals (ENTA) has 15 years of Amortizatization of Intangibles data on file, last reported at -$302000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles rose 62.99% year-over-year to -$302000.0; the trailing twelve-month figure through Mar 2026 stood at $623000.0 (up 5763.64% YoY), and the FY2025 full-year result was -$503000.0, down 144.2% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at -$302000.0, down from -$20000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $1.4 million in Q2 2023 and bottomed at -$816000.0 in Q1 2025.
- The 5-year median for Amortizatization of Intangibles is -$20000.0 (2025), against an average of $149647.1.
- The widest annual swing landed in 2024, when Amortizatization of Intangibles surged 1778.12%; it then slumped 3164.0% in 2025.
- A 5-year view of Amortizatization of Intangibles shows it stood at $339000.0 in 2022, then plunged by 180.83% to -$274000.0 in 2023, then plunged by 130.66% to -$632000.0 in 2024, then soared by 96.84% to -$20000.0 in 2025, then sank by 1410.0% to -$302000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at -$302000.0 (Q1 2026), -$20000.0 (Q4 2025), and $958000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - | -302,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -302,000.00 |
| Mar 31, 2026 | -302,000.00 |
| Dec 31, 2025 | -20,000.00 |
| Dec 31, 2025 | -20,000.00 |
| Sep 30, 2025 | 958,000.00 |
| Sep 30, 2025 | 958,000.00 |
| Jun 30, 2025 | -13,000.00 |
| Jun 30, 2025 | -13,000.00 |
| Mar 31, 2025 | -816,000.00 |
| Mar 31, 2025 | -816,000.00 |
| Dec 31, 2024 | -632,000.00 |
| Dec 31, 2024 | -632,000.00 |
| Sep 30, 2024 | 1.20 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 235,000.00 |
| Jun 30, 2024 | 235,000.00 |
| Mar 31, 2024 | -25,000.00 |
| Mar 31, 2024 | -25,000.00 |
| Dec 31, 2023 | -274,000.00 |
| Dec 31, 2023 | -274,000.00 |
| Sep 30, 2023 | 64,000.00 |
| Sep 30, 2023 | 64,000.00 |
| Jun 30, 2023 | 1.45 Mn |
| Jun 30, 2023 | 1.45 Mn |
| Mar 31, 2023 | 1.01 Mn |
| Mar 31, 2023 | 1.01 Mn |
| Dec 31, 2022 | 339,000.00 |
| Dec 31, 2022 | 339,000.00 |
| Sep 30, 2022 | -53,000.00 |
| Sep 30, 2022 | -53,000.00 |
| Jun 30, 2022 | -190,000.00 |
| Jun 30, 2022 | -190,000.00 |
| Mar 31, 2022 | -382,000.00 |
| Mar 31, 2022 | -382,000.00 |
| Dec 31, 2021 | -546,000.00 |
| Dec 31, 2021 | -546,000.00 |
| Sep 30, 2021 | -600,000.00 |
| Sep 30, 2021 | -600,000.00 |
| Jun 30, 2021 | -560,000.00 |
| Jun 30, 2021 | -560,000.00 |
| Mar 31, 2021 | -525,000.00 |
| Mar 31, 2021 | -525,000.00 |
| Dec 31, 2020 | -431,000.00 |
| Dec 31, 2020 | -431,000.00 |
| Sep 30, 2020 | -399,000.00 |
| Sep 30, 2020 | -399,000.00 |
| Jun 30, 2020 | -284,000.00 |
| Jun 30, 2020 | -284,000.00 |
| Mar 31, 2020 | 49,000.00 |
| Mar 31, 2020 | 49,000.00 |
| Dec 31, 2019 | 330,000.00 |
| Dec 31, 2019 | 330,000.00 |
| Sep 30, 2019 | 847,000.00 |
| Sep 30, 2019 | 847,000.00 |
| Jun 30, 2019 | 1.28 Mn |
| Jun 30, 2019 | 1.28 Mn |
| Mar 31, 2019 | 1.24 Mn |
| Mar 31, 2019 | 1.24 Mn |
| Dec 31, 2018 | 977,000.00 |
| Dec 31, 2018 | 977,000.00 |
| Sep 30, 2018 | 597,000.00 |
| Sep 30, 2018 | 597,000.00 |
| Jun 30, 2018 | 348,000.00 |
| Jun 30, 2018 | 348,000.00 |
| Mar 31, 2018 | -22,000.00 |
| Mar 31, 2018 | -22,000.00 |
| Dec 31, 2017 | -88,000.00 |
| Dec 31, 2017 | -88,000.00 |
| Sep 30, 2017 | -138,000.00 |
| Sep 30, 2017 | -138,000.00 |
| Jun 30, 2017 | -158,000.00 |
| Jun 30, 2017 | -158,000.00 |
| Mar 31, 2017 | -218,000.00 |
| Mar 31, 2017 | -218,000.00 |
| Dec 31, 2016 | -188,000.00 |
| Dec 31, 2016 | -188,000.00 |
| Sep 30, 2016 | -207,000.00 |
| Sep 30, 2016 | -207,000.00 |
| Jun 30, 2016 | -294,000.00 |
| Jun 30, 2016 | -294,000.00 |
| Mar 31, 2016 | -448,000.00 |
| Mar 31, 2016 | -448,000.00 |
| Dec 31, 2015 | -562,000.00 |
| Dec 31, 2015 | -562,000.00 |
| Sep 30, 2015 | -593,000.00 |
| Sep 30, 2015 | -593,000.00 |
| Jun 30, 2015 | -619,000.00 |
| Jun 30, 2015 | -619,000.00 |
| Mar 31, 2015 | -561,000.00 |
| Mar 31, 2015 | -561,000.00 |
| Dec 31, 2014 | -471,000.00 |
| Dec 31, 2014 | -471,000.00 |
| Sep 30, 2014 | -484,000.00 |
| Sep 30, 2014 | -484,000.00 |
| Jun 30, 2014 | -434,000.00 |
| Jun 30, 2014 | -434,000.00 |
| Mar 31, 2014 | -567,000.00 |
| Mar 31, 2014 | -567,000.00 |
| Dec 31, 2013 | -635,000.00 |
| Dec 31, 2013 | -635,000.00 |
| Sep 30, 2013 | -565,000.00 |
| Sep 30, 2013 | -565,000.00 |
| Jun 30, 2013 | -296,000.00 |
| Jun 30, 2013 | -296,000.00 |
| Mar 31, 2013 | -197,000.00 |
| Mar 31, 2013 | -197,000.00 |
| Dec 31, 2012 | -204,000.00 |
| Dec 31, 2012 | -204,000.00 |
| Sep 30, 2012 | -229,000.00 |
| Sep 30, 2012 | -229,000.00 |
| Jun 30, 2012 | -235,000.00 |
| Jun 30, 2012 | -235,000.00 |